Third line Treatment in Relapsed/Refractory Hodgkin's Lymphoma and Aggressive non-Hodgkin Lymphoma after 2nd line ESHAP or GEMOX

by Hamdy Zawam, Wael Edesa, Sherif Alrefai, Ahmed Abdelhafeez
Published 2018-06-01

ESHAP versus GEMOX in Management of Relapsed or Refractory Lymphoma: A Prospective Randomized Study

by Hamdy Zawam, Wael Edesa, Sherif Alrefai, Rasha Salama, Ahmed Abdelhafeez
Published 2018-06-01

Evaluation of adjuvant therapy in women with uterine papillary serous cancer

by Hamed Al Husaini, Hussein Soudy, Alaa Darwish, Mohamed Ahmed, Amin Eltigani, Wael Edesa, Mahmoud Abdelsalam
Published 2012-01-01